Important information regarding the market capitalization value of Prostatype Genomics AB (publ) on certain financial websites
Prostatype Genomics AB (the "Company") regrettably informs that some financial websites providing information services on share data and other company information, such as Avanza, Nordnet and Dagens Industri, includes the Company's ongoing rights issue in their valuation as if it was already fully subscribed and also at the current share price. This gives of course an inaccurate picture of the Company's true value. The situation is reportedly a "standard procedure” but means that the Company's value before the outcome of the rights issue is closed, is misleading. This mechanics is